|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter| 280 | Tue, 8/4/09, 8:30 AM - 10:20 AM | CC-201 |
| Statistical Issues Related to Safety Data - Contributed - Papers | ||
|
Biopharmaceutical Section, Section on Bayesian Statistical Science |
||
| Chair(s): Chul H. Ahn, FDA | ||
| 8:35 AM |
Marking the Ends of T-Waves: Algorithms and Experts —  Yingchun Zhou, National Institute of Statistical Sciences; Nell Sedransk, National Institute of Statistical Sciences
|
|
| 8:50 AM |
Diagnostics for Logistic Regression on AE Data — Bo Jin, Merck Research Laboratories
|
|
| 9:05 AM |
Handling Missing Data in the Analysis of Exposure-Adjusted Incidence Rates with Applications to Safety Endpoints in Clinical Trials — Adeniyi J. Adewale, Merck & Co., Inc.; Adam B. Polis, Merck & Co., Inc.
|
|
| 9:20 AM |
Validity and Utility of a Novel Method for Assessing Benefit-Risk Tradeoff in Clinical Trials — Maksim Pashkevich, Eli Lilly and Company; Nathan Enas, Eli Lilly and Company
|
|
| 9:35 AM |
A Bayesian Approach for Safety Monitoring in Clincal Trials — Gang Jia, Merck & Co., Inc.; Xiaoming Li, Merck Research Laboratories; Xin Zhao, Merck & Co., Inc.
|
|
| 9:50 AM |
Statistical Methods for Interval-Censored Safety Events Based on Laboratory Data — Yan Zheng, sanofi-aventis; Meehyung Cho, sanofi-aventis; William Stager, sanofi-aventis; Gerard Derzko, sanofi-aventis; Kaihong Jiang, sanofi-aventis
|
|
| 10:05 AM |
Single-Group Prospective Post-Marketing Safety Studies: A Bayesian Approach — Yu-te Wu, FDA; George Rochester, FDA; Yi Tsong, FDA
|
|
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |